Physician profile
Shade B Moody
NPI 1285844514
$193,902.83
in general payments reported to CMS, 2019-2025
17 companies · $30K in 2025
The $30K reported for 2025 was more than what 96% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $21K · 2021: $7,648 · 2022: $42K · 2023: $40K · 2024: $5,992 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $60K · Travel and Lodging: $11K · Consulting Fee: $3,120 · Food and Beverage: $1,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $60,394.00 |
| Travel and Lodging | $10,640.84 |
| Consulting Fee | $3,119.50 |
| Food and Beverage | $1,822.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $103,269.42 | 2020-2025 | Evrysdi |
| Biogen, INC. | $69,028.76 | 2019-2025 | Spinraza, Spinraza, Tecfidera |
| Novartis Gene Therapies, INC. (Fka Avexis, INC.) | $14,163.26 | 2019-2020 | |
| Genentech, INC. | $6,768.66 | 2020 | |
| Genzyme Corporation | $204.16 | 2022-2025 | |
| Abbott Laboratories | $121.71 | 2022 | |
| Janssen Scientific Affairs, LLC | $120.77 | 2022 | |
| Catalyst Pharmaceuticals, INC. | $32.70 | 2024 | |
| Philips North America LLC | $28.06 | 2019 | |
| Ns Pharma, INC. | $26.50 | 2025 | Viltepso |
| Ucb, INC. | $26.06 | 2021 | |
| Baxter Healthcare | $22.65 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Takeda Pharmaceuticals U.S.A., INC. | $21.44 | 2022 | |
| Itf Therapeutics LLC | $19.58 | 2025 | |
| Janssen Biotech, INC. | $19.36 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $15.57 | 2025 | |
| Csl Behring | $14.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shade Moody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.